"Suicide" inactivation of prostaglandin I2 synthase: characterization of mechanism-based inactivation with isolated enzyme and endothelial cells.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Archives of Biochemistry and Biophysics

• Publication date

  1995-08-20

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1006/ABBI.1995.1417PMID 7646071
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular cloning and characterization of bovine prostacyclin synthase.

  1994cited by this paper
• Molecular cloning and expression of human prostacyclin synthase.

  1994cited by this paper
• Molecular nature of phospholipases A2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells. Possible participation of cytosolic and extracellular type II phospholipases A2.

  1993cited by this paper
• Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines.

  1993cited by this paper
• Primary structure of human thromboxane synthase determined from the cDNA sequence.

  1992cited by this paper
• Molecular cloning of human platelet thromboxane A synthase.

  1991cited by this paper
• Thromboxane A2 synthase. Modification during "suicide" inactivation.

  1991cited by this paper
• Reactions and significance of cytochrome P-450 enzymes.

  1991cited by this paper
• Heparin and acidic fibroblast growth factor interact to decrease prostacyclin synthesis in human endothelial cells by affecting both prostaglandin H synthase and prostacyclin synthase

  1990cited by this paper
• "Suicide" inactivation of thromboxane A2 synthase. Characteristics of mechanism-based inactivation with isolated enzyme and intact platelets.

  1990cited by this paper
• Selective mechanism-based inactivation of the major phenobarbital-inducible P-450 cytochrome from rabbit liver by phencyclidine and its oxidation product, the iminium compound.

  1989cited by this paper
• IL-1 and related cytokines enhance thrombin-stimulated PGI2 production in cultured endothelial cells without affecting thrombin-stimulated von Willebrand factor secretion or platelet-activating factor biosynthesis.

  1989cited by this paper
• On the mechanism of prostacyclin and thromboxane A2 biosynthesis.

  1989cited by this paper
• Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man.

  1989cited by this paper
• Desensitization of agonist-stimulated prostacyclin release in human umbilical vein endothelial cells.

  1988cited by this paper
• Correlation between thrombin-induced prostacyclin production and inositol trisphosphate and cytosolic free calcium levels in cultured human endothelial cells.

  1987cited by this paper
• Analysis of 6-keto PGF1 alpha, 5-HETE, and LTC4 in rat lung: comparison of GM/MS, RIA, and EIA.

  1986cited by this paper
• Prostaglandin biosynthesis and its compartmentation in vascular smooth muscle and endothelial cells.

  1986cited by this paper
• Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate.

  1985cited by this paper
• The biochemical pharmacology of thromboxane synthase inhibition in man.

  1985cited by this paper
• Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells.

  1984cited by this paper
• Mechanism-based enzyme inactivators.

  1984cited by this paper
• Suicide substrates, mechanism-based enzyme inactivators: recent developments.

  1984cited by this paper
• Purification of prostacyclin synthase from bovine aorta by immunoaffinity chromatography. Evidence that the enzyme is a hemoprotein.

  1983cited by this paper
• Prostacyclin biosynthesis in cultured vascular endothelium is limited by deactivation of cyclooxygenase.

  1983cited by this paper
• Prostacyclin production by human endothelial and bovine smooth muscle cells in culture. Effect of repeated stimulation with arachidonic acid, thrombin and ionophore A23187.

  1983cited by this paper
• Interactions between stimulated platelets and endothelial cells in vitro.

  1981cited by this paper
• Spectral evidence for the cytochrome P450 nature of prostacyclin synthetase.

  1981cited by this paper
• Evidence for a peroxide-initiated free radical mechanism of prostaglandin biosynthesis.

  1980cited by this paper
• Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells.

  1980cited by this paper
• An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

  1976cited by this paper
• Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

  1973cited by this paper

• A new insight into subinteractomes of functional antagonists: Thromboxane (CYP5A1) and prostacyclin (CYP8A1) synthases

  2021cites this paper
• Activity of sEH and Oxidant Status during Systemic Bovine Coliform Mastitis

  2021cites this paper
• The enzymology of the human prostanoid pathway

  2020cites this paper
• A BIOPHYSICAL INVESTIGATION OF STABILITY, LIGAND BINDING, AND IRON STATE OF CYP102A1

  2020cites this paper
• The Role of the Aryl Hydrocarbon Receptor/ARNT/Cytochrome P450 System in Pulmonary Vascular Diseases- A Hypothesis.

  2019cites this paper
• Inhibition of Platelet Function by the Endothelium

  2019cites this paper
• Selenoproteins modify oxylipids from linoleic acid in macrophages

  2014cites this paper
• Regulation of inflammation by selenium and selenoproteins: impact on eicosanoid biosynthesis

  2013cites this paper
• PGI2 as a Regulator of Inflammatory Diseases

  2012cites this paper
• Hypoxia upregulates PGI-synthase and increases PGI2 release in human vascular cells exposed to inflammatory stimuli

  2011cites this paper
• COX-2 Limits Prostanoid Production in Activated HUVECs and Is a Source of PGH2 for Transcellular Metabolism to PGE2 by Tumor Cells

  2009cites this paper
• CHAPTER 13 – Inhibition of Platelet Function by the Endothelium

  2007cites this paper
• Selenium deficiency-induced alterations in the vascular system of the rat

  2007cites this paper
• Cyclooxygenase expression in human diabetes

  2006cites this paper
• Catalytic mechanisms and evolution of leukotriene A4 hydrolyse

  2006influential citation
• Cyclooxygenase and 5‐lipoxygenase pathways in the vessel wall: Role in atherosclerosis

  2004cites this paper
• Cyclooxygenase enzymes: regulation and function.

  2004cites this paper
• Dual Functionality of Cyclooxygenase-2 as a Regulator of Tumor Necrosis Factor–Mediated G1 Shortening and Nitric Oxide–Mediated Inhibition of Vascular Smooth Muscle Cell Proliferation

  2003cites this paper
• Mediated Inhibition of Vascular Smooth − Shortening and Nitric Oxide 1 Mediated G − Dual Functionality of Cyclooxygenase-2 as a Regulator of Tumor Necrosis Factor

  2003cites this paper
• Suicidal inactivation of the rabbit 15-lipoxygenase by 15S-HpETE is paralleled by covalent modification of active site peptides.

  2003cites this paper
• Sequence analysis, frequency and ethnic distribution of VNTR polymorphism in the 5'-untranslated region of the human prostacyclin synthase gene (CYP8A1).

  2002cites this paper
• Identification of amino acid residues involved in catalyses and substrate-mediated inactivation

  2001cites this paper
• Characterization of new mutations in the coding sequence and 5'-untranslated region of the human prostacyclin synthase gene (CYP8A1)

  2001cites this paper
• Regulated formation of eicosanoids.

  2001cites this paper
• Leukotriene A4 hydrolase : Identification of amino acid residues involved in catalyses and substrate-mediated inactivation

  2001cites this paper
• Human Vascular Smooth Muscle Cells but Not Endothelial Cells Express Prostaglandin E Synthase

  2000cites this paper
• Transcellular formation of thromboxane A(2) in mixed incubations of endothelial cells and aspirin-treated platelets strongly depends on the prostaglandin I-synthase activity.

  2000cites this paper
• Impact of mechanism-based enzyme inactivation on inhibitor potency: Implications for rational drug discovery

  2000cites this paper
• Purification and inactivation by substrate of an allene oxide synthase (CYP74) from corn (Zea mays L.) seeds.

  2000cites this paper
• Comparison of methods for analyzing kinetic data from mechanism-based enzyme inactivation: Application to nitric oxide synthase

  2000cites this paper
• Impact of mechanism-based enzyme inactivation on inhibitor potency: implications for rational drug discovery.

  2000cites this paper
• Rate of vasoconstrictor prostanoids released by endothelial cells depends on cyclooxygenase-2 expression and prostaglandin I synthase activity.

  1998cites this paper
• Cyclooxygenase-2 Expression and Prostaglandin I Synthase Activity Rate of Vasoconstrictor Prostanoids Released by Endothelial Cells Depends On

  1998cites this paper
• Nitric oxide modulates the activity of the hemoproteins prostaglandin I2 synthase and thromboxane A2 synthase.

  1997cites this paper
• Rate of Vasoconstrictor Prostanoids Released by Endothelial Cells Depends on Cyclooxygenase-2 Expression and Prostaglandin I Synthase Activity Original Contributions

  year unknowncites this paper